{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T13:47:14Z","timestamp":1793886434919,"version":"4.8.0"},"reference-count":16,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.2169\/internalmedicine.5305-20","type":"journal-article","created":{"date-parts":[[2020,11,8]],"date-time":"2020-11-08T22:08:07Z","timestamp":1604873287000},"page":"1109-1114","source":"Crossref","is-referenced-by-count":8,"title":["Stimulator of Interferon Genes-associated Vasculopathy with an Onset in Infancy Diagnosed after the Development of Atypical Pulmonary Lesions During Treatment as Juvenile Idiopathic Arthritis"],"prefix":"10.2169","volume":"60","author":[{"given":"Tomoya","family":"Nishida","sequence":"first","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"},{"name":"Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nakano","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshino","family":"Inoue","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Narumi-Kishimoto","sequence":"additional","affiliation":[{"name":"Medical Genome Center, National Research Institute for Child Health and Development, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Kaname","sequence":"additional","affiliation":[{"name":"Department of Genome Medicine, National Center for Child Health and Development, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[{"name":"Department of Medicine and Biosystemic Science, Kyushu University Faculty of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Tanaka","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Liu Y, Jesus AA, Marrero B, et al. Activated STING in a vascular and pulmonary syndrome. N Engl J Med 371: 507-518, 2014.","DOI":"10.1056\/NEJMoa1312625"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Ishikawa H, Barber GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signaling. Nature 455: 674-678, 2008.","DOI":"10.1038\/nature07317"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Fremond ML, Rodero MP, Nadia J, et al. Efficacy of the Janus kinase 1\/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with <i>TMEM173<\/i>-activating mutations in 3 children. J Allergy Clin Immunol 138: 1752-1755, 2016.","DOI":"10.26226\/morressier.57bc1755d462b80290b4d6b9"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Melki I, Rose Y, Uggenti C, et al. Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling. J Allergy Clin Immunol 140: 543-552.e545, 2017.","DOI":"10.1016\/j.jaci.2016.10.031"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Konig N, Fiehn C, Wolf C, et al. Familial chilblain lupus due to a gain-of-function mutation in STING. Ann Rheum Dis 76: 468-472, 2017.","DOI":"10.1136\/annrheumdis-2016-209841"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Jeremiah N, Neven B, Gentili M, et al. Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations. J Clin Invest 124: 5516-5520, 2014.","DOI":"10.1172\/JCI79100"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Clarke SL, Pellowe EJ, Jesus AA, Hilliard TN. Interstitial lung disease caused by STING-associated vasculopathy with onset in infancy. Am J Respir Crit Care Med 194: 639-642, 2016.","DOI":"10.1164\/rccm.201510-2102LE"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Omoynmi E, Gomes SM, Nanthapisal S, et al. Stimulator of interferon genes-associated vasculitis of infancy. Arthritis Rheumatol 67: 808, 2015.","DOI":"10.1002\/art.38998"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Picard C, Thouvenin G, Kannengiesser C, et al. Severe pulmonary fibrosis as the first manifestation of interferonopathy (<i>TMEM173<\/i> Mutation). Chest 150: e65-e71, 2016.","DOI":"10.1016\/j.chest.2016.02.682"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Munoz J, Rodiere M, Jeremiah N, et al. Stimulator of interferon genes-associated vasculopathy with onset in infancy a mimic of childhood granulomatosis with polyangiitis. JAMA Dermatol 151: 872-877, 2015.","DOI":"10.1001\/jamadermatol.2015.0251"},{"key":"11","unstructured":"11. Kawai T. STING-associated vasculopathy with onset in infancy (SAVI). Nippon Rinsho 76: 1825-1821, 2018 (in Japanese, Abstract in English)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Gina A, Reinhardt A, Ramsey S, et al. JAK1\/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies. J Clin Invest 128: 3041-3052, 2018.","DOI":"10.1172\/JCI98814"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Sasaki H, Yanagi K, Ugi S, et al. Definitive diagnosis of mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome caused by a recurrent <i>de novo<\/i> mutation in the POLD1 gene. Endocr J 65: 227-238, 2018.","DOI":"10.1507\/endocrj.EJ17-0287"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. M\u00e9gane N, Aur\u00e9lie G, Norinne L-Q, et al. Self-DNA release and STING-dependent sensing drives inflammation to cigarette smoke in mice. Sci Rep 9: 14848, 2019.","DOI":"10.1038\/s41598-019-51427-y"},{"key":"15","unstructured":"15. Tanaka Y. Recent progress and perspective in JAK inhibitors for rheumatoid arthritis: from bench to bedside. J Biochem 158: 173-179, 2015."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Tanaka Y, Maeshima K, Yamaoka K. <i>In vitro<\/i> and <i>in vivo<\/i> analysis of a JAK inhibitor in rheumatoid arthritis. Ann Rheum Dis 71: i70-i74, 2012.","DOI":"10.1136\/annrheumdis-2011-200595"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/7\/60_5305-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,27]],"date-time":"2022-11-27T07:56:28Z","timestamp":1669535788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/7\/60_5305-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5305-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}